Emerging Infectious Disease ISSN: 1080-6059

Human Parechovirus-3 and Neonatal Infections

Guy Boivin*

, Yacine Abed*, and François D. Boucher*

Author affiliations: *Centre Hospitalier Universitaire de Québec and Laval University, Québec City, Québec, Canada

Appendix

Figure. Comparison of the predicted amino acid sequences of human parechovirus (HPeV)-3 Canadian isolates no. 81235, 81554, and 82853 with reference sequences of HPeV-1, -2 and -3 (GenBank accession no. S45208, AF055846, and AB084913, respectively) for the VP0-VP3-VP1 proteins (8,10). Asterisks denote identical residues in all strains, whereas shaded amino acids highlight changes between HPeV-3 isolates. The RGD motif present only in HPeV-1 and -2 strains is underlined. The HPeV-1 immunodominant

Appendix. Figure. Comparison of the predicted amino acid sequences of human parechovirus (HPeV)-3 Canadian isolates no. 81235, 81554, and 82853 with reference sequences of HPeV-1, -2 and -3 (GenBank accession no. S45208, AF055846, and AB084913, respectively) for the VP0-VP3-VP1 proteins (8,10). Asterisks denote identical residues in all strains, whereas shaded amino acids highlight changes between HPeV-3 isolates. The RGD motif present only in HPeV-1 and -2 strains is underlined. The HPeV-1 immunodominant epitope described by Joki-Korpela et al. (15) is shown in bold.

Main Article

Top of Page

The opinions expressed by authors contributing to this journal do not necessarily reflect the opinions of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.